Evidence map›Paper›PMID 34577554›Full record

ReviewPharmaceuticals (Basel, Switzerland)2021

Inulin and Its Application in Drug Delivery.

Franklin Afinjuomo, Sadikalmahdi Abdella, Souha H Youssef, Yunmei Song, Sanjay Garg

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 107 citations in OpenAlex.

  1. Polysaccharides and carbohydrate polymers: innovations from nature to industry.Journal of the science of food and agriculture · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Franklin AfinjuomoPharmaceutical Innovation and Development Group, Clinical and Health Sciences, University of South Australia, Adelaide 5001, Australia.ORCID 0000-0002-0851-9419
Sadikalmahdi AbdellaPharmaceutical Innovation and Development Group, Clinical and Health Sciences, University of South Australia, Adelaide 5001, Australia.
Souha H YoussefPharmaceutical Innovation and Development Group, Clinical and Health Sciences, University of South Australia, Adelaide 5001, Australia.ORCID 0000-0003-1670-6211
Yunmei SongPharmaceutical Innovation and Development Group, Clinical and Health Sciences, University of South Australia, Adelaide 5001, Australia.ORCID 0000-0003-0008-5895
Sanjay GargPharmaceutical Innovation and Development Group, Clinical and Health Sciences, University of South Australia, Adelaide 5001, Australia.ORCID 0000-0001-7253-2629
University of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inulin's unique and flexible structure, stabilization/protective effects, and organ targeting ability make it an excellent drug delivery carrier compared to other biodegradable polysaccharides. The three hydroxyl groups attached to each fructose unit serve as an anchor for chemical modification. This, in turn, helps in increasing bioavailability, improving cellular uptake, and achieving targeted, sustained, and controlled release of drugs and biomolecules. This review focuses on the various types of inulin drug delivery systems such as hydrogel, conjugates, nanoparticles, microparticles, micelles, liposomes, complexes, prodrugs, and solid dispersion. The preparation and applications of the different inulin drug delivery systems are further discussed. This work highlights the fact that modification of inulin allows the use of this polymer as multifunctional scaffolds for different drug delivery systems.

Indexed as

drug deliveryhydrogelsinulinmicroparticlesnanoparticles

Identifiers

PMID34577554
PMCPMC8468356
OpenAlexW3195781485

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.